AIM Cancellation - Summit Therapeutics PLC (7948D)
24 Fevereiro 2020 - 4:00AM
UK Regulatory
TIDMSUMM
RNS Number : 7948D
AIM
24 February 2020
NOTICE
24/02/2020
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON
At the request of the Company the following securities have been
cancelled from trading on AIM with effect from the time and date of
this notice.
SUMMIT THERAPEUTICS PLC
213800NRW8AOMYMTBD89
ORDINARY SHARES (BN40HZ0)(GB00BN40HZ01) SUMT THER/PAR VTG FDP 0.01
OF 1P EACH, FULLY
PAID
----------------------- --------------------------
If you have any queries or require further information, please
contact the company's nominated adviser +44 (0)20 7213 0880.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
AMOUASVRRRUUUAR
(END) Dow Jones Newswires
February 24, 2020 02:00 ET (07:00 GMT)
Summit Therapeutics (LSE:SUMM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Summit Therapeutics (LSE:SUMM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Summit Therapeutics Plc da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Summit Therapeutics Plc